Cagrilintide + Semaglutide Blend combines two synthetic acylated peptides for laboratory research.
Cagrilintide + Semaglutide Blend combines two acylated peptides:
Cagrilintide – 39-amino acid DACRA with C20 fatty di-acid and Cys3-Cys8 disulfide bridge.
Semaglutide – 31-amino acid GLP-1 receptor agonist with Aib8 and C18 fatty di-acid at Lys26.
Both feature fatty acid modifications for albumin binding. Combined lyophilized powder requiring reconstitution. Store at -20°C.
Disclaimer: For laboratory and research purposes only. Not intended for human consumption.